Clinical Trials Browser

Recurrence × enzastaurin × Gynecologic × Clear all

NCT00420381 2020-12-19

Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer

Phase 2 Completed

28 enrolled 13 charts

Carcinoma, Neoplasms, Ovarian Neoplasms, Recurrence